| Biological Information | |
|---|---|
| Background Information: | IBMX, also referred to as 3-isobutyl-1-methylxanthine, is a competitive phosphodiesterase inhibitor which raises cAMP levels, activates PKA, inhibits TNF-alpha, synthesizes leukotrienes, and reduces a number of inflammation and innate immune mechanisms. IBMX also is known among the class of compounds to act as a nonselective adenosine receptor antagonist. |
| Target Name: | Ultrapure IBMX |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Ultrapure IBMX
IBMX is a competitive phosphodiesterase inhibitor. This product is provided as 55.55 mg of dry powder.
Datasheets
92-0007 Datasheet
View Document